John Monahan - Director, Anixa Biosciences Inc

As of April 29, 2019


John Monahan Net Worth

  • Net worth is estimated to be at least $311.78K
  • Owns at least 50,900 units of Anixa Biosciences Inc stock

John Monahan Trading

  • Largest purchase of shares was 900 units , worth over $3.8K on April 29, 2019
  • In total has made about 2 transactions over a year
  • Usually trades in October and April, with the busiest year in 2018 and 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Anixa Biosciences Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Other Earnings Plans or Compensations
Dr. Amit Kumar 2020 $521,625 $160,000 $1,674,400 $39,240 $2,395,265
Dr. Amit Kumar 2019 $476,250 $150,000 - $39,240 $665,490
Michael J. Catelani 2020 $287,219 $50,000 $322,000 - $659,219
Michael J. Catelani 2019 $263,021 $50,000 - - $313,021
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/715446/000149315221008414/def14-a.htm

Anixa Biosciences Inc Insider Trading

  • The most recent transaction was 30,000 units bought on July 28, 2021 by Lewis H. Titterton Jr. worth over $126.3K
  • In the last 3 years, insiders at Anixa Biosciences Inc bought an estimated value of $2.1M
  • The most active traders are Lewis H. Titterton Jr., Director,  Amit Kumar, Chief Executive Officer,  and Arnold M Baskies, Director
  • Insider trading is most common in October, with the busiest year in 2021

Anixa Biosciences Inc Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1